Nohla Therapeutics initiates Phase 2 LAUNCH clinical trial to assess optimal dosage of innovative cell therapy for those with acute myeloid leukemia. A treatment made from umbilical cord blood is helping oncology and hematology specialists at Norton Cancer Institute reduce infections in patients getting high-dose chemotherapy to treat acute myeloid leukemia (AML). The intensive chemotherapy…
Intrauterine transfusion is an essential treatment for severe fetal anemia. The procedure is performed between 18 and 35 weeks after fetal ultrasound is suggestive of fetal anemia or hydrops. In a sterile environment, fetal blood is obtained via percutaneous umbilical blood sampling. Transfusion is recommended for a fetal hematocrit less than 30 cc, which can…
Norton Women’s Care launched the MOST (Maternal Opiate Substance Treatment) Program as a resource for pregnant women who suffer from substance use disorders. Treatment services designed specifically for pregnant women dependent on drugs or alcohol are hard to find. Many programs are reluctant to accept pregnant women, partly due to the lack of knowledge about…
A “high-risk pregnancy” can mean many things. However, pregnant women who need extra care to have a healthy pregnancy and delivery should be referred to a maternal-fetal medicine specialist. Norton Children’s Maternal-Fetal Medicine provides services in Louisville, Paducah and Bowling Green, Kentucky, and Madison, Indiana. The practice offers: Diagnosis and counseling for fetal abnormalities and…